Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Grossman

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Urology|July 1, 1986
Complications of 125I implantation: inability to deflate Foley catheterH B Grossman
Urology|May 19, 2001
Biomarkers for transitional cell carcinoma-proH B Grossman
Seminars in Urology|February 1, 1985
Tumor markers in urologyH B Grossman
The Journal of Urology|August 1, 1978
The late recurrence of grade I transitional cell carcinoma of the ureter after conservative therapyH B Grossman
The Urologic Clinics of North America|August 1, 1986
Clinical applications of monoclonal antibody technologyH B Grossman
Urology|February 1, 1980
Acute ureteral obstruction from buckshotA Montealegre, H B Grossman
Human Gene Therapy|January 10, 2002
Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with CisplatinM Tanaka, H B Grossman
The Urologic Clinics of North America|March 4, 2000
The utility of fibrin/fibrinogen degradation products in superficial bladder cancerJ Tsihlias, H B Grossman
Cancer|July 1, 1989
Bladder carcinoma in patients age 40 years or youngerJ Wan, H B Grossman
Journal of Surgical Oncology|April 1, 1988
Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinomaU Khanderia, H B Grossman
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Urology|July 1, 1986
Complications of 125I implantation: inability to deflate Foley catheterH B Grossman
Urology|May 19, 2001
Biomarkers for transitional cell carcinoma-proH B Grossman
Seminars in Urology|February 1, 1985
Tumor markers in urologyH B Grossman
The Journal of Urology|August 1, 1978
The late recurrence of grade I transitional cell carcinoma of the ureter after conservative therapyH B Grossman
The Urologic Clinics of North America|August 1, 1986
Clinical applications of monoclonal antibody technologyH B Grossman
Urology|February 1, 1980
Acute ureteral obstruction from buckshotA Montealegre, H B Grossman
Human Gene Therapy|January 10, 2002
Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with CisplatinM Tanaka, H B Grossman
The Urologic Clinics of North America|March 4, 2000
The utility of fibrin/fibrinogen degradation products in superficial bladder cancerJ Tsihlias, H B Grossman
Cancer|July 1, 1989
Bladder carcinoma in patients age 40 years or youngerJ Wan, H B Grossman
Journal of Surgical Oncology|April 1, 1988
Evaluation of N-acetylneuraminic acid, carcinoembryonic antigen, and alpha-fetoprotein as markers for advanced carcinomaU Khanderia, H B Grossman
Pageof 16